SlideShare a Scribd company logo
1 of 7
Download to read offline
What percentage of newly 
diagnosed breast cancer are 
stage 4? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
What percentage of newly 
diagnosed breast cancer are 
stage 1? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
What percentage of newly 
diagnosed breast cancer are 
stage 3? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
What percentage of newly 
diagnosed breast cancer are 
hormone receptor positive? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
What percentage of newly 
diagnosed breast cancer are 
Her -2 Neu positive? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
Your choice of hormone therapy 
in adjuvant setting 
• Initial AI for 5 year 
• Initial AI for 10 year 
• 5 year AI then 5 years TAM 
• 5 year TAM and then 5 year of AI 
• 10 year TAM 
• 5 year TAM 
• Other
Your choice of hormone therapy 
in adjuvant setting 
• Initial AI for 5 year 
• Initial AI for 10 year 
• 5 year AI then 5 years TAM 
• 5 year TAM and then 5 year of AI 
• 10 year TAM 
• 5 year TAM 
• Other

More Related Content

Viewers also liked

Revisão decreto-lei-concursos-e-moibilidade-docentes
Revisão decreto-lei-concursos-e-moibilidade-docentesRevisão decreto-lei-concursos-e-moibilidade-docentes
Revisão decreto-lei-concursos-e-moibilidade-docentesDo outro lado da barricada
 
Peristiwa Morfologis, by Nuril Anwar SMK Negeri 10 Malang
Peristiwa Morfologis, by Nuril Anwar SMK Negeri 10 MalangPeristiwa Morfologis, by Nuril Anwar SMK Negeri 10 Malang
Peristiwa Morfologis, by Nuril Anwar SMK Negeri 10 MalangNuril anwar
 
Let's holly qur'an
Let's holly qur'anLet's holly qur'an
Let's holly qur'anNuril anwar
 
Biography of Interview
Biography of InterviewBiography of Interview
Biography of Interviewmurni mohamat
 
1404 06 ss-i-mobile概要資料
1404 06 ss-i-mobile概要資料1404 06 ss-i-mobile概要資料
1404 06 ss-i-mobile概要資料i-mobile Co.,Ltd
 
Tiempo metorologuico
Tiempo metorologuicoTiempo metorologuico
Tiempo metorologuicosanjoel
 
Ivailo dimitrov-2014
Ivailo dimitrov-2014Ivailo dimitrov-2014
Ivailo dimitrov-2014Sim Aleksiev
 
HPV related Gynecological Cancers
HPV related Gynecological CancersHPV related Gynecological Cancers
HPV related Gynecological Cancersspa718
 
What needs to happen - Tasmanian Shellfish Executive Council
What needs to happen - Tasmanian Shellfish Executive CouncilWhat needs to happen - Tasmanian Shellfish Executive Council
What needs to happen - Tasmanian Shellfish Executive Councilprogressive01
 
SysFy iOS Work proposal
SysFy iOS Work proposalSysFy iOS Work proposal
SysFy iOS Work proposaltalktosysfy
 
Orlowski mm rel_ref_celgene
Orlowski mm rel_ref_celgeneOrlowski mm rel_ref_celgene
Orlowski mm rel_ref_celgenespa718
 
Unidad 8 tema 2 act de aprendizaje 1_kenia hernandez flores
Unidad 8 tema 2 act de aprendizaje 1_kenia hernandez floresUnidad 8 tema 2 act de aprendizaje 1_kenia hernandez flores
Unidad 8 tema 2 act de aprendizaje 1_kenia hernandez floresKENYAHF10
 
Newsletter 6 pdf
Newsletter 6  pdfNewsletter 6  pdf
Newsletter 6 pdfmaymaskow1
 
Presentación1
Presentación1Presentación1
Presentación1sanjoel
 
Ата-аналарға ақпарат
Ата-аналарға  ақпаратАта-аналарға  ақпарат
Ата-аналарға ақпаратISAEDU
 
Qula: The Story of our Startup
Qula: The Story of our StartupQula: The Story of our Startup
Qula: The Story of our StartupArtyom Moskvin
 

Viewers also liked (20)

Revisão decreto-lei-concursos-e-moibilidade-docentes
Revisão decreto-lei-concursos-e-moibilidade-docentesRevisão decreto-lei-concursos-e-moibilidade-docentes
Revisão decreto-lei-concursos-e-moibilidade-docentes
 
Peristiwa Morfologis, by Nuril Anwar SMK Negeri 10 Malang
Peristiwa Morfologis, by Nuril Anwar SMK Negeri 10 MalangPeristiwa Morfologis, by Nuril Anwar SMK Negeri 10 Malang
Peristiwa Morfologis, by Nuril Anwar SMK Negeri 10 Malang
 
A operação marquês e os negócios
A operação marquês e os negóciosA operação marquês e os negócios
A operação marquês e os negócios
 
Let's holly qur'an
Let's holly qur'anLet's holly qur'an
Let's holly qur'an
 
Biography of Interview
Biography of InterviewBiography of Interview
Biography of Interview
 
1404 06 ss-i-mobile概要資料
1404 06 ss-i-mobile概要資料1404 06 ss-i-mobile概要資料
1404 06 ss-i-mobile概要資料
 
Tiempo metorologuico
Tiempo metorologuicoTiempo metorologuico
Tiempo metorologuico
 
Ivailo dimitrov-2014
Ivailo dimitrov-2014Ivailo dimitrov-2014
Ivailo dimitrov-2014
 
Pannathon tunyavanich(presentation)
Pannathon tunyavanich(presentation)Pannathon tunyavanich(presentation)
Pannathon tunyavanich(presentation)
 
HPV related Gynecological Cancers
HPV related Gynecological CancersHPV related Gynecological Cancers
HPV related Gynecological Cancers
 
What needs to happen - Tasmanian Shellfish Executive Council
What needs to happen - Tasmanian Shellfish Executive CouncilWhat needs to happen - Tasmanian Shellfish Executive Council
What needs to happen - Tasmanian Shellfish Executive Council
 
SysFy iOS Work proposal
SysFy iOS Work proposalSysFy iOS Work proposal
SysFy iOS Work proposal
 
Orlowski mm rel_ref_celgene
Orlowski mm rel_ref_celgeneOrlowski mm rel_ref_celgene
Orlowski mm rel_ref_celgene
 
Unidad 8 tema 2 act de aprendizaje 1_kenia hernandez flores
Unidad 8 tema 2 act de aprendizaje 1_kenia hernandez floresUnidad 8 tema 2 act de aprendizaje 1_kenia hernandez flores
Unidad 8 tema 2 act de aprendizaje 1_kenia hernandez flores
 
О мерах по повышению эффективности и развитию НП «Совет рынка».
О мерах по повышению эффективности и развитию НП «Совет рынка». О мерах по повышению эффективности и развитию НП «Совет рынка».
О мерах по повышению эффективности и развитию НП «Совет рынка».
 
Newsletter 6 pdf
Newsletter 6  pdfNewsletter 6  pdf
Newsletter 6 pdf
 
Presentación1
Presentación1Presentación1
Presentación1
 
Ата-аналарға ақпарат
Ата-аналарға  ақпаратАта-аналарға  ақпарат
Ата-аналарға ақпарат
 
Qula: The Story of our Startup
Qula: The Story of our StartupQula: The Story of our Startup
Qula: The Story of our Startup
 
Las vegas commercial photographers
Las vegas commercial photographersLas vegas commercial photographers
Las vegas commercial photographers
 

Similar to Ars breast cancer

How to diagnose prostate cancer better in 2017 - IDF presentation
How to diagnose prostate cancer better in 2017 - IDF presentationHow to diagnose prostate cancer better in 2017 - IDF presentation
How to diagnose prostate cancer better in 2017 - IDF presentationMarc Laniado
 
Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018Robert J Miller MD
 
1. dr r saha breast cancer screening npcdcs_dept. of community med
1. dr r saha  breast cancer screening npcdcs_dept. of community med1. dr r saha  breast cancer screening npcdcs_dept. of community med
1. dr r saha breast cancer screening npcdcs_dept. of community meddrdduttaM
 
USToo: About Prostate Cancer
USToo: About Prostate CancerUSToo: About Prostate Cancer
USToo: About Prostate CancerPCAinAZ
 
Screening and prostate cancer
Screening and prostate cancerScreening and prostate cancer
Screening and prostate cancerDr Ankur Shah
 
PSA test accuracy
PSA test accuracyPSA test accuracy
PSA test accuracyGaetan Lion
 
Epidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 apEpidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 apletymbou
 
POC Breast 1 | 2007 - Adjuvant Endocrine Therapy
POC Breast 1 | 2007 -  	Adjuvant Endocrine TherapyPOC Breast 1 | 2007 -  	Adjuvant Endocrine Therapy
POC Breast 1 | 2007 - Adjuvant Endocrine Therapyrtp
 
Bayesian clinical test
Bayesian clinical testBayesian clinical test
Bayesian clinical testGaetan Lion
 

Similar to Ars breast cancer (20)

Breast Cancer Screening Presentation - PiPP
Breast Cancer Screening Presentation - PiPPBreast Cancer Screening Presentation - PiPP
Breast Cancer Screening Presentation - PiPP
 
How to diagnose prostate cancer better in 2017 - IDF presentation
How to diagnose prostate cancer better in 2017 - IDF presentationHow to diagnose prostate cancer better in 2017 - IDF presentation
How to diagnose prostate cancer better in 2017 - IDF presentation
 
Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018
 
Us2aware
Us2awareUs2aware
Us2aware
 
1. dr r saha breast cancer screening npcdcs_dept. of community med
1. dr r saha  breast cancer screening npcdcs_dept. of community med1. dr r saha  breast cancer screening npcdcs_dept. of community med
1. dr r saha breast cancer screening npcdcs_dept. of community med
 
pca screening.pdf
pca screening.pdfpca screening.pdf
pca screening.pdf
 
Prof Richard Peto on Breast Cancer Screening
Prof Richard Peto on Breast Cancer ScreeningProf Richard Peto on Breast Cancer Screening
Prof Richard Peto on Breast Cancer Screening
 
Prostate health
Prostate healthProstate health
Prostate health
 
ABC1 - P. Francis - Elderly patients
ABC1 - P. Francis - Elderly patientsABC1 - P. Francis - Elderly patients
ABC1 - P. Francis - Elderly patients
 
Postmenapausal bleding
Postmenapausal bledingPostmenapausal bleding
Postmenapausal bleding
 
USToo: About Prostate Cancer
USToo: About Prostate CancerUSToo: About Prostate Cancer
USToo: About Prostate Cancer
 
Screening and prostate cancer
Screening and prostate cancerScreening and prostate cancer
Screening and prostate cancer
 
Cancer screening for seniors
Cancer screening for seniorsCancer screening for seniors
Cancer screening for seniors
 
Breast cancer lecture by Roel Tolentino, MD, MBA
Breast cancer   lecture by Roel Tolentino, MD, MBABreast cancer   lecture by Roel Tolentino, MD, MBA
Breast cancer lecture by Roel Tolentino, MD, MBA
 
PSA test accuracy
PSA test accuracyPSA test accuracy
PSA test accuracy
 
CCSN EUPROMS.pptx
CCSN EUPROMS.pptxCCSN EUPROMS.pptx
CCSN EUPROMS.pptx
 
Epidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 apEpidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 ap
 
POC Breast 1 | 2007 - Adjuvant Endocrine Therapy
POC Breast 1 | 2007 -  	Adjuvant Endocrine TherapyPOC Breast 1 | 2007 -  	Adjuvant Endocrine Therapy
POC Breast 1 | 2007 - Adjuvant Endocrine Therapy
 
Prostate video 1
Prostate video 1Prostate video 1
Prostate video 1
 
Bayesian clinical test
Bayesian clinical testBayesian clinical test
Bayesian clinical test
 

More from spa718

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotaispa718
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery spa718
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancerspa718
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancerspa718
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerspa718
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinomaspa718
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancerspa718
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancerspa718
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancerspa718
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancerspa718
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancerspa718
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancerspa718
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancerspa718
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015spa718
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancerspa718
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHDspa718
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myelomaspa718
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapyspa718
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapyspa718
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Updatespa718
 

More from spa718 (20)

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancer
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancer
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinoma
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancer
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancer
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancer
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancer
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancer
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancer
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancer
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancer
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHD
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myeloma
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapy
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapy
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Update
 

Ars breast cancer

  • 1. What percentage of newly diagnosed breast cancer are stage 4? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 2. What percentage of newly diagnosed breast cancer are stage 1? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 3. What percentage of newly diagnosed breast cancer are stage 3? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 4. What percentage of newly diagnosed breast cancer are hormone receptor positive? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 5. What percentage of newly diagnosed breast cancer are Her -2 Neu positive? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 6. Your choice of hormone therapy in adjuvant setting • Initial AI for 5 year • Initial AI for 10 year • 5 year AI then 5 years TAM • 5 year TAM and then 5 year of AI • 10 year TAM • 5 year TAM • Other
  • 7. Your choice of hormone therapy in adjuvant setting • Initial AI for 5 year • Initial AI for 10 year • 5 year AI then 5 years TAM • 5 year TAM and then 5 year of AI • 10 year TAM • 5 year TAM • Other